Skip to content

Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity

by M C Moore
Curr Opin Investig Drugs ()


Spherix Inc (formerly Biospherics) is developing tagatose, an orally active lactose derivative for the potential treatment of obesity and type 2 diabetes. The compound is also under investigation for the potential treatment of anemia, hemophilia and medical problems related to infertility, birth weight and excessive maternal food intake. Phase I and II clinical trials have been completed.

Cite this document (BETA)

Readership Statistics

2 Readers on Mendeley
by Discipline
50% Agricultural and Biological Sciences
50% Energy
by Academic Status
100% Student > Ph. D. Student

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in